Atlas Trials

Dose Individualization of Pemetrexed - IMPROVE-III

Clinical trial NCT03655834 · COMPLETED

Trial details

NCT number
NCT03655834
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Non Small Cell Lung CancerMesothelioma
Start date
2019-02-01
Primary completion
2020-09-20
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.